| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-09-09 17:55 Tx date 2025-09-05 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+1,000,000 vol |
1,000,000 | |
| Filed 2025-09-09 17:55 Tx date 2018-08-27 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-09-09 17:54 Tx date 2025-09-05 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$50,000
+1,000,000 vol $0.05 each |
1,891,300 | |
| Filed 2024-11-15 15:52 Tx date 2023-06-26 |
$UDOC
UniDoc Health Corp. |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
25,000 | |
| Filed 2024-11-15 15:46 Tx date 2024-04-02 |
$UDOC
UniDoc Health Corp. |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Warrants Unit Warrants
37 - Stock split or consolidation
|
+25,000 vol |
50,000 | |
| Filed 2024-11-15 14:50 Tx date 2024-04-02 |
$UDOC
UniDoc Health Corp. |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+25,000 vol |
50,000 | |
| Filed 2023-09-28 15:42 Tx date 2023-06-26 |
$UDOC
UniDoc Health Corp. |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
||
| Filed 2024-04-16 13:08 Tx date 2024-04-15 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,360
-144,000 vol $0.065 each |
891,300 | |
| Filed 2024-04-16 13:07 Tx date 2024-04-15 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-110.50
-1,700 vol $0.065 each |
1,035,300 | |
| Filed 2024-03-27 12:49 Tx date 2024-03-22 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,225
-403,000 vol $0.075 each |
1,037,000 | |
| Filed 2023-09-28 15:42 Tx date 2023-06-26 |
$UDOC
UniDoc Health Corp. |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
25,000 | |
| Filed 2023-09-28 15:42 Tx date 2023-04-28 |
$UDOC
UniDoc Health Corp. |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-20,000 vol |
0 | |
| Filed 2023-06-21 21:29 Tx date 2021-03-22 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,000
+50,000 vol $0.12 each |
350,000 | |
| Filed 2023-06-21 21:29 Tx date 2020-08-10 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,000
+300,000 vol $0.12 each |
300,000 | |
| Filed 2021-03-23 19:26 Tx date 2021-03-22 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+50,000 vol $0.30 each |
||
| Filed 2020-08-12 14:35 Tx date 2020-08-10 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$90,000
+300,000 vol $0.30 each |
||
| Filed 2021-12-23 16:10 Tx date 2021-12-22 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,742.81
-88,571 vol $0.11 each |
1,440,000 | |
| Filed 2021-04-12 10:38 Tx date 2018-08-27 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-08-12 14:16 Tx date 2018-08-27 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-23 19:26 Tx date 2021-03-22 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+50,000 vol $0.30 each |
1,878,571 |